Search - tctmd.com

Displaying 61 - 80 of 243

Sort: Relevancy | Date

Presentation TCT Abstracts Posters 2018

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Presenter: Woo-Young Chung

September 25, 2018

Presentation TCT Abstracts Posters 2018

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

Presenter: Imanol Otaegui

September 25, 2018

Presentation TCT 2018

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Michael Haude, Robert-Jan van Geuns, Yaling Han

September 23, 2018

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

Presentation TCT 2018

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

Presenter: Alexandre Abizaid, Didier Carrié, Julia Ellert

September 21, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Conference News CRT 2018

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Michael O'Riordan

March 08, 2018

News Industry News

SELUTION™ First-in-Man Study Achieves Primary Endpoint

January 31, 2018

Presentation TCT 2017

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Piotr P. Buszman

November 01, 2017

News Daily News

Boston Scientific Scraps Biodegradable Scaffold Program

Michael O'Riordan

August 01, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

News Industry News TCT 2016

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

November 02, 2016

News Industry News TCT 2016

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

November 02, 2016

Presentation TCT 2016

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Pieter C. Smits

October 31, 2016

Presentation TCT 2016

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Li Zhi

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Advertisement

Long Term Clinical Outcomes With Biodegradable Polymer Sirolimus-eluting Stents Versus Durable Polymer Sirolimus-eluting Stents

Intrapatient randomised study with polymer free DES vs. abluminal biodegradable polymer DES with early OCT follow-up

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

TCT-90: Clinical Outcomes Three Year After Revascularization With a Biodegradable Polymer Ultra-thin Strut Sirolimus-Eluting Stent and a Biodegradable Polymer Biolimus-eluting Stent. From the SORT OUT VII Trial

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

SELUTION™ First-in-Man Study Achieves Primary Endpoint

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Boston Scientific Scraps Biodegradable Scaffold Program

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions

TCT 261: Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-Eluting and Birolimus-Eluting Stents with Biodegradable Polymer. From the SORT OUT VII Trial

TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content